Beijing Konruns Pharmaceutical Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
5 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 5 with minor changes only.
-
Minor: 5 trials marked Unknown by the registry's verification sweep Changed
- Minor: Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: KC1036 · Advanced Thymic Tumors Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: KC1036 in the · Advanced Digestive System Tumors Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: KC1036 · Advanced Solid Tumors Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: CX1003 (Kanitinib) · Advanced Solid Tumors Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-16 | NCT07937605 KC1086 in Combination With Fulvestrant for HR-Positive, HER2-Negative Advanced Breast… | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 1 | |
| Phase 2 | 3 | |
| Phase 3 | 1 |
Disease areas by active trials
Esophageal Cancer (2) · Breast Cancer (1) · Sarcoma (1)
Get alerts when Beijing Konruns Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.